Delivery Order SPE2DH25D0001-SPE2D425F144M
- Not listed
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $2,178.28 on June 2, 2025, for CG4+ Test Cartridges (Blue) with an ultimate completion date of June 4, 2025. This fixed-price contract with economic price adjustment was issued by the Defense Medical Supply Chain without set-aside designation, indicating full and open competition. The place of performance is North Chicago, Illinois, where Abbott maintains its headquarters and point-of-care...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $4,836.00 for CG4+ Test Cartridge (Blue) on July 14, 2025, with an ultimate completion date of July 16, 2025. The contract is a fixed price delivery order with economic price adjustment provisions and was awarded without a set-aside designation, indicating full and open competition. The Medical Supply Chain, a Defense agency component, is the funding federal agency, with the place of...
- Abbott Laboratories Inc., through its Abbott Point of Care division, has been awarded a delivery order valued at $4,030.00 for CG4+ test cartridges (white) by the Medical Supply Chain, a defense-focused federal agency. The contract, awarded on September 26, 2025, with an ultimate completion date of September 30, 2025, is structured as a fixed-price delivery order with economic price adjustment provisions. The place of performance is located in North Chicago, Illinois, where Abbott maintains...
- Abbott Laboratories Inc., through its Abbott Point of Care division, has been awarded a delivery order valued at $1,713.50 by the Medical Supply Chain division of the Department of Defense for CG4+ test cartridges (blue). This fixed price contract with economic price adjustment was awarded on August 7, 2025, with an ultimate completion date of August 11, 2025, and will be performed in North Chicago, Illinois. The contract was awarded through full and open competition with no set-aside...
- Abbott Laboratories Inc., through its Abbott Point of Care division, has been awarded a delivery order contract for CG4+ Test Cartridge (Blue) by the Medical Supply Chain, a defense-focused federal agency. The contract, awarded on July 14, 2025, carries a ceiling value of $1,007.50 and is structured as a fixed-price delivery order with economic price adjustment provisions. The work will be performed in North Chicago, Illinois, and the contract contains no set-aside designation, indicating it was...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $1,576.00 by the Medical Supply Chain division of the Department of Defense on August 11, 2025, with an ultimate completion date of August 13, 2025. The contract involves the supply of a CG4+ Test Cartridge (Blue), a point-of-care diagnostic testing product. The award utilized full and open competition with no set-aside designation, indicating that the contract was competed among all...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $15,778.58 on July 28, 2025, for CG4+ test cartridges (blue) under a fixed-price contract with economic price adjustment provisions. The contract, which carries no set-aside designation and indicates full and open competition, is set to be completed by July 30, 2025, with performance taking place at Abbott's facility in North Chicago, Illinois. This delivery order is funded by the...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $1,929.00 for CG4+ Test Cartridge (Blue) effective August 15, 2025, with an ultimate completion date of August 19, 2025. This fixed-price contract with economic price adjustment provision was awarded without a set-aside designation, indicating full and open competition. The contract is funded by the Defense Medical Supply Chain and will be performed at Abbott's facility in North Chicago,...
- Abbott Laboratories Inc. has been awarded a delivery order valued at $1,007.50 for CG4+ Test Cartridge (Blue) under a fixed price contract with economic price adjustment provisions. The award, issued on August 5, 2025, with an ultimate completion date of August 7, 2025, supports the Medical Supply Chain within the Defense sector. The contract represents a child award with no set-aside designation, indicating full and open competition. Performance will take place at Abbott's North Chicago,...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order on June 25, 2025, for CG4+ Test Cartridge (Blue) with a ceiling value of $1,539.00. This fixed-price contract with economic price adjustment was issued without a set-aside designation, indicating full and open competition. The products will be performed in North Chicago, Illinois, and the contract is scheduled for ultimate completion by June 27, 2025. The funding agency is the Defense Logistics...
- SPE2DH25D0001Indefinite Delivery Contract
- SPE2DH25D0001-SPE2D425F144MDelivery Order
Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $2,418.00 for CG4+ Test Cartridge (Blue) on April 24, 2025, with an ultimate completion date of April 28, 2025. The contract is a fixed-price delivery order with economic price adjustment provisions and was awarded by the Medical Supply Chain, a defense-oriented federal agency. The award was made through full and open competition with no set-aside designation, and performance will take place at Abbott's facility in North Chicago, Illinois. This delivery order represents a task order against a larger indefinite delivery vehicle and reflects Abbott Laboratories' substantial presence in federal medical diagnostics procurement. The company supplies critical point-of-care testing products and diagnostic reagents to federal agencies, particularly the Department of Veterans Affairs across multiple regional networks. The CG4+ Test Cartridge is consistent with Abbott's portfolio of in-vitro diagnostic testing supplies, which support clinical laboratory operations and diagnostic capabilities within federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 4/24/25 |